The report calls on US actors to engage with Chinese firms as the AI landscape continues to evolve China's open-source ...
License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applications ...